Physician profile
Asim Roy
NPI 1639159767
$666,250.26
in general payments reported to CMS, 2019-2025
28 companies · $64K in 2025
The $64K reported for 2025 was more than what 98% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114K · 2020: $86K · 2021: $130K · 2022: $97K · 2023: $74K · 2024: $101K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Honoraria: $56K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Travel and Lodging: $13K · Food and Beverage: $6,511 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,100 · Education: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $117,709.41 |
| Honoraria | $55,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,556.00 |
| Travel and Lodging | $13,193.35 |
| Food and Beverage | $6,510.98 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,100.00 |
| Education | $411.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $313,358.40 | 2019-2025 | |
| Inspire Medical Systems, INC. | $154,562.95 | 2019-2025 | Inspire |
| Harmony Biosciences LLC | $80,273.68 | 2020-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $69,064.77 | 2023-2025 | Lumryz |
| Eisai INC. | $16,221.61 | 2019-2022 | |
| Lilly USA, LLC | $16,135.87 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $12,150.44 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $1,254.00 | 2024 | |
| Resmed Corp | $1,000.00 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $916.66 | 2023 | |
| Azurity Pharmaceuticals, INC. | $239.60 | 2023-2025 | Horizant, Horizant |
| Zoll Respicardia, INC. | $211.61 | 2022-2024 | Remede System |
| Respire Medical Holdings LLC | $192.98 | 2022 | |
| Noctrix Health, INC. | $132.78 | 2024 | Nidra |
| Itamar Medical INC | $117.87 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $95.65 | 2021 | |
| Arbor Pharmaceuticals, INC. | $90.02 | 2020-2022 | |
| Fisher & Paykel Healthcare INC | $49.62 | 2024 | Fisher & Paykel Healthcare |
| Vanda Pharmaceuticals INC. | $48.57 | 2022-2023 | Hetlioz |
| Vertical Pharmaceuticals, LLC | $31.96 | 2019 | |
| Idorsia Pharmaceuticals US INC | $30.87 | 2022-2023 | Quviviq |
| 3b Medical, INC. | $25.77 | 2023 | Luna |
| Somnomed INC. | $23.74 | 2024 | |
| Medicomp INC | $20.84 | 2023 | Telepatch Cardiac Monitor |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asim Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.